{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:51:14Z","timestamp":1782449474733,"version":"3.54.5"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:p>This case describes a 66-year-old man with long-standing type 1 diabetes (diagnosed in 1969) complicated by polyneuropathy, autonomic neuropathy with hypoglycemia unawareness, and advanced diabetic retinopathy. Despite many years of treatment and consistent self-management, he experienced substantial glycemic variability, chronic hyperglycemia (HbA1c 9.2%), and a pronounced fear of hypoglycemia that led to insulin underdosing and maladaptive coping behaviors. Following admission to the Diabetes Clinic of the University Hospital in Krakow, structured diabetes education and psychological support were provided. The patient was subsequently enrolled in a research program and transitioned to the MiniMed\u2122 780G Advanced Hybrid Closed Loop (AHCL) system, which automatically adjusts insulin delivery based on continuous glucose monitoring. After nine months of AHCL use, the patient showed clinically meaningful improvement in CGM-derived metabolic outcomes (mean glucose 128 mg\/dL, GMI 6.4%, TIR 91%, TBR 1%), with no episodes of severe hypoglycemia reported during follow-up. Standardized psychological assessment showed improvement in well-being and reductions in diabetes-related distress and depressive symptoms: WHO-5 increased from 9 to 14, DDS global score decreased from 3.2 to 1.8, PHQ-9 decreased from 7 to 3, and PAID global score decreased from 42 to 35. This CARE-based case report illustrates that AHCL therapy, when implemented together with structured education and psychological support, may be associated with improved glycemic outcomes and reduced psychological burden in selected older adults with long-standing type 1 diabetes. The findings should be interpreted cautiously because they derive from a single case.<\/jats:p>","DOI":"10.3389\/fcdhc.2026.1870978","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:35:52Z","timestamp":1782448552000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Advanced hybrid closed-loop therapy in an older adult with 55-year type 1 diabetes: a CARE-based case report"],"prefix":"10.3389","volume":"7","author":[{"given":"Kamila","family":"Susu\u0142","sequence":"first","affiliation":[{"name":"Department of Metabolic Diseases and Diabetology, University Hospital in Krak\u00f3w","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Matejko","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases and Diabetology, University Hospital in Krak\u00f3w","place":["Krak\u00f3w, Poland"]},{"name":"Department of Metabolic Diseases, Centre for Advanced Technologies in Diabetes, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]},{"name":"Department of Metabolic Diseases, Psychodiabetology Unit, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Sudu\u0142","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases and Diabetology, University Hospital in Krak\u00f3w","place":["Krak\u00f3w, Poland"]},{"name":"Department of Metabolic Diseases, Centre for Advanced Technologies in Diabetes, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]},{"name":"Department of Metabolic Diseases, Psychodiabetology Unit, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej T.","family":"Ma\u0142ecki","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases and Diabetology, University Hospital in Krak\u00f3w","place":["Krak\u00f3w, Poland"]},{"name":"Department of Metabolic Diseases, Centre for Advanced Technologies in Diabetes, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Klupa","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases and Diabetology, University Hospital in Krak\u00f3w","place":["Krak\u00f3w, Poland"]},{"name":"Department of Metabolic Diseases, Centre for Advanced Technologies in Diabetes, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]},{"name":"Department of Metabolic Diseases, Psychodiabetology Unit, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Cyranka","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases and Diabetology, University Hospital in Krak\u00f3w","place":["Krak\u00f3w, Poland"]},{"name":"Department of Metabolic Diseases, Centre for Advanced Technologies in Diabetes, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]},{"name":"Department of Metabolic Diseases, Psychodiabetology Unit, Jagiellonian University Medical College","place":["Krak\u00f3w, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14807","article-title":"Predictors of time in target glucose range in real-world users of the MiniMed 780G system","volume":"24","author":"Castaneda","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0274-2","article-title":"Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy","volume":"48","author":"Matejko","year":"2015","journal-title":"Endocrine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2196\/43535","article-title":"Improvement of selected psychological parameters and quality of life of patients with type 1 diabetes mellitus undergoing transition from multiple daily injections and self-monitoring of blood glucose directly to the MiniMed 780G advanced hybrid closed-loop system: post hoc analysis of a randomized control study","volume":"24","author":"Cyranka","year":"2023","journal-title":"JMIR Form Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus recommendations for the use of automated insulin delivery technologies in clinical practice","volume":"44","author":"Phillip","year":"2023","journal-title":"Endocr Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0018","article-title":"Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the joint diabetes technology working group of the european association for the study of diabetes and the american diabetes association","volume":"45","author":"Sherr","year":"2022","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-022-01937-5","article-title":"Switching to the Minimed\u2122 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control","volume":"59","author":"Lepore","year":"2022","journal-title":"Acta Diabetol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-0470","article-title":"Transitioning of people with type 1 diabetes from multiple daily injections and self-monitoring of blood glucose directly to MiniMed 780G advanced hybrid closed-loop system: a two-center, randomized. Controlled Study","volume":"45","author":"Matejko","year":"2022","journal-title":"Diabetes Care"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0059","article-title":"One-year follow-up of advanced hybrid closed-loop system in adults with type 1 diabetes previously naive to diabetes technology: the effect of switching to a calibration-free sensor","volume":"25","author":"Matejko","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-021-01157-0","article-title":"The cost-effectiveness of an advanced hybrid closed-loop system in people with type 1 diabetes: a health economic analysis in Sweden","volume":"12","author":"Jendle","year":"2021","journal-title":"Diabetes Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.766314","article-title":"Six-month effectiveness of advanced vs. standard hybrid closed-loop system in children and adolescents with type 1 diabetes mellitus","volume":"9","author":"Tornese","year":"2021","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1870978\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:35:59Z","timestamp":1782448559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1870978\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":10,"alternative-id":["10.3389\/fcdhc.2026.1870978"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2026.1870978","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"1870978"}}